Questionnaire for Stomach Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to gather health information to better understand and prevent gastric cancer by studying individuals with early signs of potential cancer development. Participants will include those with stomach conditions that could lead to cancer, such as gastric atrophy (thinning of the stomach lining), intestinal metaplasia (change in stomach lining cells), and dysplasia (abnormal cell growth). Healthy individuals and those with early-stage gastric cancer will also participate for comparison. This study suits individuals diagnosed with these stomach conditions or early gastric cancer who are not currently undergoing active cancer treatment.
As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could lead to improved prevention strategies for gastric cancer.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to gather comprehensive health information to better understand and prevent gastric cancer. Unlike existing treatments that focus on managing the disease after it develops, this study explores the early stages, such as atrophic gastritis and intestinal metaplasia, to identify patterns and factors that contribute to cancer progression. By analyzing data from both affected individuals and healthy controls, the study hopes to uncover insights that could lead to earlier detection and more effective prevention strategies. This proactive approach has the potential to transform how gastric cancer is tackled, shifting the focus from treatment to prevention.
Who Is on the Research Team?
Monika Laszkowska, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Registry Creation
Participants with precursor lesions, gastric cancer, and healthy controls are enrolled to create a registry
Follow-up
Participants are monitored for progression of precursor lesions and comparison of baseline characteristics
What Are the Treatments Tested in This Trial?
Interventions
- Questionnaire
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Participants with gastric cancer
Participants with presence of atrophic gastritis, intestinal metaplasia, and dysplasia and risk of the progression of these lesions
Healthy controls
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.